ArticleThe New England journal of medicine2016
Ibrutinib for Chronic Lymphocytic Leukemia.
Article in The New England journal of medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Risk of Invasive Fungal Infections in Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors: A Case-Control Propensity Score-Matched Analysis.Open forum infectious diseases · 2024Article
- Invasive Fungal Infections and Targeted Therapies in Hematological Malignancies.Journal of fungi (Basel, Switzerland) · 2021Review
- Article
- Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.Clinical microbiology reviews · 2020Review
- A case of CNS aspergillosis in a patient with chronic lymphocytic leukemia on first-line ibrutinib therapy.Medical mycology case reports · 2020Article
- Isolated central nervous system Aspergillosis infection in a chronic lymphocytic leukemia patient on Ibrutinib: A case report.BMC infectious diseases · 2020Article
- Mucormycosis of the Central Nervous System.Journal of fungi (Basel, Switzerland) · 2019Review
- Cranial aspergillosis in a patient receiving ibrutinib for chronic lymphocytic leukemia.Medical mycology case reports · 2019Article
- Antibody immunity and natural resistance to cryptococcosis.Current tropical medicine reports · 2019Article
- Immunological changes with kinase inhibitor therapy for chronic lymphocytic leukemia.Leukemia & lymphoma · 2018Review
- Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018Article
- Review
- Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018Article
- Invasive Fungal Infections in Patients with Chronic Lymphoproliferative Disorders in the Era of Target Drugs.Mediterranean journal of hematology and infectious diseases · 2018Review
- Experience with ibrutinib for first-line use in patients with chronic lymphocytic leukemia.Therapeutic advances in hematology · 2018Review
- Current Status of Bruton's Tyrosine Kinase Inhibitor Development and Use in B-Cell Malignancies.Drugs & aging · 2017Review
- Article
- Invasive aspergillosis related to ibrutinib therapy for chronic lymphocytic leukemia.Respiratory medicine case reports · 2017Article
- Disseminated Cryptococcosis With Brain Involvement in Patients With Chronic Lymphoid Malignancies on Ibrutinib.Open forum infectious diseases · 2017Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
27096597What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.